✦ LIBER ✦

[14] CLEARANCE OF HCVRNA WITH VALOPICITABINE (NM) PLUS PEG-INTERFERON IN TREATMENT-NAIVE PATIENTS WITH HCV-1 INFECTION: RESULTS AT 24 AND 48 WEEKS

✍ Scribed by E. Lawitz; T. Nguyen; Z. Younes; J. Santoro; N. Gitlin; D. McEniry; R. Chasen; J. Goff; D. Dieterich; S. Knox; K. Kleber; B. Belanger; N.A. Brown

Book ID: 117375117
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 130 KB
Volume: 46
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(07)61612-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

736 Early clearance of HCV RNA with valo

736 Early clearance of HCV RNA with valopicitabine (NM283) plus PEG-Interferon in treatment-naïve patients with HCV-1 infection: First results from a phase IIb trial

✍ D. Dieterich; E. Lawitz; T. Nguyen; Z. Younes; J. Santoro; N. Gitlin; D. McEniry 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 248 KB

93 Enhanced antiviral efficacy for valop

93 Enhanced antiviral efficacy for valopicitabine (NM283) plus peg-interferon in hepatitis C patients with HCV genotype-1 infection: Results of a phase IIa multicenter trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Su1065 Longer Therapy With 48 Weeks of P

Su1065 Longer Therapy With 48 Weeks of Pegylated Interferon and Ribavirin (PEG IFN+RBV) Is Superior to 24 Weeks in Patients With Treatment-Naive Hepatitis C Virus Genotype 6 (HCV-6): A Meta-Analysis of 641 Patients

✍ Nguyen, Nghia; McCormack, Shelley A.; Yee, Brittany E.; Nguyen, Mindie H. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 243 KB

66 HIGH SUSTAINED VIRAL RESPONSE AT 12-

66 HIGH SUSTAINED VIRAL RESPONSE AT 12- AND 24-WEEK FOLLOW-UP OF MK-5172 WITH PEGYLATED INTERFERON alfa-2b AND RIBAVIRIN (PR) IN HCV GENOTYPE 1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS

✍ Manns, M.; Vierling, J.M.; Bacon, B.R.; Marcellin, P.; Caro, L.; Gress, J.; Gilb 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB